Efanesoctocog alfa for the treatment and prevention of bleeding episodes in patients with haemophilia A

NICE

17 May 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use of efanesoctocog alfa in the NHS in England.

For the time being, efanesoctocog alfa is not recommended for the treatment and prevention of bleeding episodes in patients with haemophilia A.

Read NICE draft guidance consultation

Michael Wonder

Posted by:

Michael Wonder